‘We must have a plan’: Why we need an exit strategy for the coronavirus shutdown

| | March 24, 2020
ap
A woman walks through a lightly trafficked Times Square in New York. Credit: Associated Press/Seth Wenig
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

How long is this going to last? As terrible as a pandemic would be, is averting it really worth a new Great Depression? What is the endgame?

As a pandemic loomed, the country moved in remarkably short order from shrug to shutdown. Understandably, some are already questioning the wisdom of this move, noting how little information we’re acting on and the devastation the shutdown is already wreaking on the economy. The New York Times grants shutdown skepticism the frisson of “taboo.”

Much of this skepticism still misunderstands just how devastating the pandemic would be — not only in lives lost but in damage to the economy. The skeptics are wrong in the near term. For now, we have no other choice. But they are right that this cure cannot be tolerated for long. And they are right too that there is no consensus on when the shutdown will have achieved its aim, or on when the benefits will no longer outweigh the costs.

Related article:  COVID-19 evolving to be less deadly? Experts challenge Italian doctor's claims

We urgently need a better understanding of why the shutdown is necessary, under what conditions it will be relaxed, and what we all must do to achieve that transition. The present uncertainty imperils not only the economy but the effort against the pandemic. We must have a plan now.

Read the original post

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend